Dear Sir,Pursuant to SEBI (Prohibition of Insider Trading Regulations), 2015 as amended and in compliance with the terms of code of conduct of the company, please note that Trading Window for dealing in the securities of the company will remain closed for the designated persons and their immediate relatives from Thursday 1st Day of January 2026 till the completion of 48 hours after the date of declaration of Unaudited financial results of the company for Quarter and Nine Months ended on 31st December 2025
Closure of Trading Window
Filed with BSE · · 1 page · English
Release
Earlier from Omkar Pharmachem
- Results- Unaudited Financial Results For September, 2025
- Omkar Pharmachem Ltd. Press Release Nov 14 2025
- Board Meeting Outcome for Outcome Of The Board Meeting Held On 14Th November, 2025
- Omkar Pharmachem Ltd. Press Release Nov 06 2025
- Board Meeting Intimation for Board Meeting Intimation For Inter-Alia, To Consider, Approve And Take On Record The Unaudited Standalone Financial Results Of The Company For The Quarter And Half Yearly Ended September 30, 2025
Later from Omkar Pharmachem
- Announcement Under Regulation 30- Update- Re-Lodgment Of Transfer Of Shares Request Report For The Month Of December 2025
- Omkar Pharmachem Ltd. Press Release Jan 07 2026
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Omkar Pharmachem Ltd. Press Release Jan 10 2026
- Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Change In Composition Of Committees Of The Board And Change In Name Of Company Secretary And Compliance Officer Of The Company.
Follow Omkar Pharmachem into a list and get an email when it puts out news.
Follow Omkar Pharmachem